Clinical Trial

The Clinical Effect of Sugammadex Sodium (Domestic) for Antagonizing Neuromuscular Blockade After Thoracic Surgery

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 17, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to compare the use of sugammadex (domestic) and neostigmine for antagonism after thoracic surgery, and observe the effect of sugammadex (domestic) on neuromuscular blockade antagonism after thoracic surgery, in order to provide a basis for optimizing the use of muscle relaxants and their antagonists during anesthesia.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-03-27.
Status change: Not Yet Recruiting → Recruiting 2025-02-14
Trial Details
NCT Number NCT06334562
Lead Sponsor The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Conditions Neuromuscular Blockade
Enrollment 80 participants
Start Date 2024-06-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-17